Locally Advanced or Metastatic Malignant Solid Tumors
2 competing products in clinical development for Locally Advanced or Metastatic Malignant Solid Tumors.
Pipeline by Phase
Phase 1/21
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ASP2998 + Pembrolizumab + Enfortumab Vedotin + Carboplatin | Astellas Pharma | Phase 1/2 | Recruiting | 39 |
| enfortumab vedotin + pembrolizumab | Astellas Pharma | Phase 2 | Active | 39 |